Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and without Cocaine Dependence. uri icon

Overview

abstract

  • This corrects the article DOI: 10.1038/npp.2017.205.

publication date

  • March 1, 2018

Identity

PubMed Central ID

  • PMC5809793

Scopus Document Identifier

  • 85041845943

Digital Object Identifier (DOI)

  • 10.1038/npp.2017.245

PubMed ID

  • 29422497

Additional Document Info

volume

  • 43

issue

  • 4